FDA OKs Higher-Dose Naloxone Nasal Spray for Opioid Overdose

The US Food and Drug Administration (FDA) has approved a higher-dose naloxone hydrochloride nasal spray (Kloxxado) for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. Kloxxado delivers 8 mg of naloxone into the nasal cavity, which is twice as much as the 4 mg of […]

Drinking, drunk, deadly: Know the signs of alcohol overdose

Wednesday is St. Patrick’s Day, a holiday often marked by one (or more) too many drinks. But experts warn that simple holiday fun can quickly turn deadly when alcohol is involved. The U.S. National Institute on Alcohol Abuse and Alcoholism (NIAAA) offered these reminders about the dangers of alcohol overdose and urged everyone to drink […]

Ceftriaxone Alphapharm

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CEFTRIAXONE ALPHAPHARM contains the active ingredient ceftriaxone CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Ceftriaxone Alphapharm. It does not contain all of the available information. It does not take the place of talking to […]

Terry White Chemists Duloxetine

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS DULOXETINE Contains the active ingredient duloxetine (as duloxetine hydrochloride) Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine. This leaflet answers some common questions about duloxetine. It does not contain all the […]

Tofranil

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TOFRANIL® 10 mg and 25 mg tablets Imipramine hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Tofranil. It does not contain all the available information. It does not take the place of talking to […]

Trileptal

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TRILEPTAL® oxcarbazepine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Trileptal. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in […]

Carboplatin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CARBOPLATIN INJECTION Carboplatin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Carboplatin Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All […]

Paracetamol BNM

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PARACETAMOL BNM 1000 mg/100 mL solution for infusion paracetamol Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you are given Paracetamol BNM. This leaflet answers some common questions about Paracetamol BNM. It does not contain all […]

Tobi

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TOBI® SOLUTION FOR INHALATION Solution for Inhalation tobramycin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about TOBI Solution for Inhalation (“TOBI”). It does not contain all the available information. It does not take the place […]

Ketamine APOTEX

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KETAMINE APOTEX Solution for Injection Ketamine hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about this medicine. It does not contain all the available information. It does not take the place of talking to your […]